Now, hold onto your hats, folks, because a contrarian signal’s flashing brighter than a firefly convention. Could this be the buying opportunity of a lifetime in the wild west of derivatives? 🤠
Warren Buffett’s name carries weight in financial circles. Under his leadership, Berkshire Hathaway has become a symbol of consistent market outperformance. Its latest 13F filing shows a new position in UnitedHealth Group (UNH), a company that has seen its stock decline 40% since August 18.
The FDA approved Wegovy for MASH on Friday. Not just any approval-this is a religious experience in a lab coat. MASH is a disease where fat accumulates in the liver like a drunken party. Twenty-two million Americans are infected, 9 million of them bleeding out in clinics. And yet, the FDA only approved one other drug for this hellhole last year. Now, Novo is throwing its hat into the ring with a GLP-1 drug that’s already a household name for weight loss. But here’s the kicker: Wegovy isn’t starting from zero. It’s already a legend, with phase 3 results that could make a priest weep. And Novo? It’s a colossus with a marketing budget that could buy a small country. This isn’t a market-it’s a land grab.
According to CoinGlass data, Dogecoin long traders, in the last one hour, recorded a tempest of liquidations, a 343,069% imbalance against short trades. Notably, the long position lost $148,880 within 60 minutes as the price shifted, a spectacle as thrilling as watching a toddler attempt to balance a teacup. 🧸
Why does this matter? Because Kenvue now makes up 3.8% of Sender’s equity Assets Under Management (AUM). Here’s a list of their top holdings as of this filing:
The CoinDesk 20 is currently sitting at a respectable 4005.12, down 1.4% (-55.83) since the clock struck 4 p.m. ET on Wednesday. Oof, that’s gotta sting! 😬
Consider MercadoLibre, that restless spirit haunting the vast, untamed expanse of Latin America. Its tale is one of feverish ambition-a merchant prince striding through a land of 650 million souls, yet grasping at shadows. For what is e-commerce but a Sisyphean bargain? Each fulfilled order, each humming fulfillment center, merely delays the inevitable reckoning with entropy. Yet still it climbs.
A doubling of one’s purse in five years? A compound annual growth rate of 15.3%! One might call it respectable-though scarcely worthy of the gasps reserved for true financial alchemy.
Whispers abound concerning President Donald Trump’s purported plans to host an Ultimate Fighting Championship (UFC) event at the White House next July 4th-a notion so audacious it might well have been penned by Miss Austen herself, had she lived to witness such modern absurdities. But while society marvels at this peculiar prospect, one cannot help but wonder whether they truly understand the entity behind UFC. For those who value discernment over distraction, familiarity with TKO becomes imperative.
Per the SEC’s gilded scrolls, their hoard now gleams at $46.15 billion. The recent 430 BTC? A mere trinket, purchased with $19.3 million from STRK, $19 million from STRF, and $12.1 million from STRD-each penny a drop in the ocean of their hubris. Michael Saylor, that modern-day Midas, hinted at further buys with a cryptic “Not enough orange” post-a riddle for the ages. 🍊